Bill
A 6987
Bill A 6987 requires healthcare providers in the 340B program to report drug discounts to the Department of Health, ensuring savings benefit low-income patients effectively.
Bill Number: A 6987
Title: Requires covered entities to report to the Department of Health regarding certain 340B drug discounts
Status: Referred to Health
Introduced: March 18, 2025
Classification: Bill
Bill A 6987 aims to enhance transparency and accountability in the 340B drug discount program by requiring covered entities to report specific information to the Department of Health. The 340B program allows eligible healthcare providers to purchase outpatient drugs at reduced prices, which can help them serve low-income and uninsured patients. This legislation seeks to ensure that the benefits of the program are effectively utilized and monitored.
Reporting Requirements: Covered entities participating in the 340B program will be mandated to submit detailed reports to the Department of Health. These reports will include:
Compliance and Oversight: The Department of Health will be responsible for reviewing the submitted reports to ensure compliance with the 340B program regulations. This oversight aims to prevent misuse of the program and ensure that discounts are being passed on to patients as intended.
Implementation Timeline: While specific implementation dates are not outlined in the current version of the bill, the requirement for reporting will likely be established following the bill's passage and subsequent regulatory processes.
Covered Entities: Hospitals, clinics, and other healthcare providers that participate in the 340B program will be directly impacted by the new reporting requirements. These entities will need to allocate resources to compile and submit the necessary data.
Department of Health: The Department will have increased responsibilities for monitoring compliance and analyzing the data submitted by covered entities.
Patients: Ultimately, the bill aims to benefit patients by ensuring that the savings from the 340B program are effectively utilized to improve access to medications and healthcare services for low-income and uninsured populations.
Bill A 6987 represents a significant step toward improving the oversight of the 340B drug discount program. By mandating reporting from covered entities, the legislation seeks to ensure that the program's benefits are maximized for the communities it is designed to serve. As the bill progresses through the legislative process, further details regarding implementation and compliance will likely emerge.
Compiled from official sources — confirm details with the bill’s official record.
Sign in to ask a question.
